JEFFREY RATHMELL and W. KIMRYN RATHMELL were both appointed to leadership roles at Vanderbilt University Medical Center.
MASSIMO CRISTOFANILLI was appointed associate director for precision medicine and translational research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and director of Northwestern OncoSET.
FRANCIS COLLINS, director of the NIH, was awarded the Leadership in Personalized Medicine Award by the Personalized Medicine Coalition. He will be presented the award during the Personalized Medicine Conference at Harvard Medical School Nov. 19.
ROBERT DIPAOLA, STEPHEN GRUBER and CANDACE JOHNSON were elected to the board of directors of the Association of American Cancer Institutes. Their three-year terms will begin Oct. 25, during the annual meeting of the AACI and the Cancer Center Administrators Forum in Washington, D.C.
FDA approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting.
EDITH MITCHELL was named president of the National Medical Association, at the organization's 113th annual convention and scientific assembly in Detroit Aug 4. Mitchell is a professor of medical oncology at Thomas Jefferson University.
Cancer researcher Sidney Mirvish died at age 86. His research into nitrosamines and carcinogenesis led to changes in the way lunch meats, hot dogs and sausages were made.
FDA granted priority review for MCNA, developed by Telesta Therapeutics Inc.
FDA granted Orphan Drug Designation for MTG-201, a therapy targeting Dickkopf-3 gene defects in various cancers, for the treatment of malignant mesothelioma.
The American Society of Clinical Oncology issued an updated policy statement on genetic and genomic testing for cancer susceptibility.